hemispherx biopharma inc (HEB:NYSE Amex)
Robert Dickey IV
Chief Financial Officer and Vice President, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
Mr. Robert Dickey, Rob, IV serves as Chief Financial Officer of Neostem, Inc. Mr. Dickey serves as Managing Director of DSS Partners LLC. Mr. Dickey served as a Senior Vice President of Hemispherx Biopharma, Inc. since June 2009 until August 16, 2013. Mr. Dickey served as the Chief Financial Officer and Senior Vice President of StemCyte, Inc. since July 2007. He served as the Chief Financial Officer and Vice President of Finance of Locus Pharmaceuticals, Inc. since December ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*
Former Senior Director
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Christopher J. Calhoun||Co-Founder, Vice Chairman, Chief Executive Officer and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin P. Rosendale||Chief Executive Officer and Director|
|Gary H. Rabin||Chairman, Chief Executive Officer and Member of Nominating & Corporate Governance Committee|
Advanced Cell Technology Inc.
|Zami Aberman||Executive Chairman, Chief Executive Officer and President|
Pluristem Therapeutics, Inc.
|$544.2K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Boston, MA | TripAdvisor LLCPosted: Dec 05
- Asheville, NC | Mission HospitalsPosted: Dec 05